Also, we demonstrated significant attenuation in caspase-3 expression with GLP1 and SGLT2i treatment, suggesting that inhibition of apoptosis might be a mechanism for the cardioprotective effects of these agents against DCM. This evidence concerns the gene GCG and familial dilated cardiomyopathy.